These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 26007164)

  • 41. Glioblastoma recurrence patterns after radiation therapy with regard to the subventricular zone.
    Adeberg S; König L; Bostel T; Harrabi S; Welzel T; Debus J; Combs SE
    Int J Radiat Oncol Biol Phys; 2014 Nov; 90(4):886-93. PubMed ID: 25220720
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Immunohistochemical expression of stem cell markers CD44 and nestin in glioblastomas: Evaluation of their prognostic significance.
    Guadagno E; Borrelli G; Califano M; Calì G; Solari D; Del Basso De Caro M
    Pathol Res Pract; 2016 Sep; 212(9):825-32. PubMed ID: 27450656
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Mesenchymal/proangiogenic factor YKL-40 related to glioblastomas and its relationship with the subventricular zone.
    Batista KMP; Eulate-Beramendi SA; Pińa KYÁR; Figueira PR; Canal AF; Chasin JMA; Meilan Á; Ugalde R; Vega IF
    Folia Neuropathol; 2017; 55(1):14-22. PubMed ID: 28430288
    [No Abstract]   [Full Text] [Related]  

  • 44. Differential localization of glioblastoma subtype: implications on glioblastoma pathogenesis.
    Steed TC; Treiber JM; Patel K; Ramakrishnan V; Merk A; Smith AR; Carter BS; Dale AM; Chow LM; Chen CC
    Oncotarget; 2016 May; 7(18):24899-907. PubMed ID: 27056901
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model.
    Wang CH; Rockhill JK; Mrugala M; Peacock DL; Lai A; Jusenius K; Wardlaw JM; Cloughesy T; Spence AM; Rockne R; Alvord EC; Swanson KR
    Cancer Res; 2009 Dec; 69(23):9133-40. PubMed ID: 19934335
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Magnetic resonance imaging characteristics of glioblastoma multiforme: implications for understanding glioma ontogeny.
    Bohman LE; Swanson KR; Moore JL; Rockne R; Mandigo C; Hankinson T; Assanah M; Canoll P; Bruce JN
    Neurosurgery; 2010 Nov; 67(5):1319-27; discussion 1327-8. PubMed ID: 20871424
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The extent of edema and tumor synchronous invasion into the subventricular zone and corpus callosum classify outcomes and radiotherapy strategies of glioblastomas.
    Liang HT; Chen WY; Lai SF; Su MY; You SL; Chen LH; Tseng HM; Chen CM; Kuo SH; Tseng WI
    Radiother Oncol; 2017 Nov; 125(2):248-257. PubMed ID: 29056290
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Proliferation index is related to patient age in glioblastoma.
    McKeever PE; Junck L; Strawderman MS; Blaivas M; Tkaczyk A; Cates MA; Yan M; Li L
    Neurology; 2001 May; 56(9):1216-8. PubMed ID: 11342691
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Quick Uptakes: Sex-Specific Tumor Signatures Help Explain Differences in Glioblastoma Survival.
    Sancar F
    JAMA; 2019 Mar; 321(9):824-825. PubMed ID: 30758495
    [No Abstract]   [Full Text] [Related]  

  • 50. Assessing the influence of subventricular zone contact of glioblastomas with gross total resection on patient survival.
    Mistry AM
    J Clin Neurosci; 2018 Jun; 52():165. PubMed ID: 29602603
    [No Abstract]   [Full Text] [Related]  

  • 51. WEEKLY clinicopathological exercises: glioblastoma multiforme with hemorrhage into lateral ventricle.
    N Engl J Med; 1951 Nov; 245(22):860-3. PubMed ID: 14882439
    [No Abstract]   [Full Text] [Related]  

  • 52. A GLO10 score for the prediction of prognosis in high grade gliomas.
    Chen F; Peng P; Zhou Y; Yang ZY; Zhang HQ; Ao XS; Zhou DQ; Xiang CX
    Oncotarget; 2017 Sep; 8(41):70899-70906. PubMed ID: 29050331
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Using 3D MRI Anatomic Maps to Determine Prognosis for Glioblastomas.
    Huang RY
    Radiology; 2019 Dec; 293(3):644-645. PubMed ID: 31596185
    [No Abstract]   [Full Text] [Related]  

  • 54. Perilesional edema in brain cancer: Independent prognosticator or epiphenomenon of biomolecular signature?
    Nardone V; Vinciguerra C; Federico A; Cerase A; Pirtoli L; Tini P
    Radiother Oncol; 2018 Oct; 129(1):183-184. PubMed ID: 29331541
    [No Abstract]   [Full Text] [Related]  

  • 55. Response to 'Perilesional edema in brain cancer: Independent prognosticator or epiphenomenon of biomolecular signature?'.
    Liang HT; Tseng WI
    Radiother Oncol; 2018 Oct; 129(1):185-186. PubMed ID: 29343408
    [No Abstract]   [Full Text] [Related]  

  • 56. Endfoot regrowth for neural stem cell renewal.
    Tsuboi M; Gotoh Y
    Nat Cell Biol; 2020 Jan; 22(1):3-5. PubMed ID: 31871316
    [No Abstract]   [Full Text] [Related]  

  • 57. Sociocognitive approach to behaviour change for reducing low-value care.
    Scott IA; McPhail SM
    Aust Health Rev; 2021 Mar; 45(2):173-177. PubMed ID: 33250069
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Impact of glycemia on survival of glioblastoma patients treated with radiation and temozolomide.
    Tieu MT; Lovblom LE; McNamara MG; Mason W; Laperriere N; Millar BA; Ménard C; Kiehl TR; Perkins BA; Chung C
    J Neurooncol; 2015 Aug; 124(1):119-26. PubMed ID: 26015297
    [TBL] [Abstract][Full Text] [Related]  

  • 59. A phase I study of cediranib in combination with cilengitide in patients with recurrent glioblastoma.
    Gerstner ER; Ye X; Duda DG; Levine MA; Mikkelsen T; Kaley TJ; Olson JJ; Nabors BL; Ahluwalia MS; Wen PY; Jain RK; Batchelor TT; Grossman S
    Neuro Oncol; 2015 Oct; 17(10):1386-92. PubMed ID: 26008604
    [TBL] [Abstract][Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.